Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Genes and Development Année : 2006

Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.

Thordur Oskarsson
  • Fonction : Auteur
Marieke Alida Gertruda Essers
  • Fonction : Auteur
Nicole Dubois
  • Fonction : Auteur
Sandra Offner
  • Fonction : Auteur
Christelle Dubey
  • Fonction : Auteur
Catherine Roger
  • Fonction : Auteur
Edith Hummler
  • Fonction : Auteur
Peter Beard
  • Fonction : Auteur
Andreas Trumpp

Résumé

The target gene(s) required for Myc-mediated tumorigenesis are still elusive. Here we show that while endogenous c-Myc is surprisingly dispensable for skin homeostasis and TPA-induced hyperplasia, c-Myc-deficient epidermis is resistant to Ras-mediated DMBA/TPAinduced tumorigenesis. This is mechanistically linked to p21(Cip1), which is induced in tumors by the activated Ras-ERK pathway but repressed by c-Myc. Acute elimination of c-Myc in established tumors leads to the up-regulation of p21(Cip1), and epidermis lacking both p21(Cip1) and c-Myc reacquires normal sensitivity to DMBA/TPA-induced tumorigenesis. This identifies c-Myc-mediated repression of p21(Cip1) as a key step for Ras-driven epidermal tumorigenesis.

Dates et versions

hal-00188093 , version 1 (15-11-2007)

Identifiants

Citer

Thordur Oskarsson, Marieke Alida Gertruda Essers, Nicole Dubois, Sandra Offner, Christelle Dubey, et al.. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.. Genes and Development, 2006, 20 (15), pp.2024-9. ⟨10.1101/gad.381206⟩. ⟨hal-00188093⟩
233 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More